University College Dublin has launched legal proceedings against Applied Process, co-founded by two of its professors, for a stake in the company.

The infectious disease drug developer has raised $30m in a round featuring Asahi Kasei, SR One and Lundbeckfonden Ventures.

Johnson & Johnson and AstraZeneca helped fund a $15.6m round for PhaseBio that included $7.5m in debt financing from Silicon Valley Bank.

The medical imaging technology developer has secured $30.2m in a series B round featuring SoftBank subsidiary SBCVC and will use the funding for hiring.

GV has participated in a series D round for Fractyl Laboratories, which is developing minimally-invasive treatment for metabolic diseases.

Medtronic, Novartis and SinoPharm are among the investors in a series B round for Harvard spinout Semma Therapeutics, which is working on a treatment for patients suffering from diabetes.

Maina Bhaman has joined Sofinnova Partners after serving as director of healthcare investment at Touchstone Innovations for over a decade.

Alexandria Venture Investments was among the investors in a series C round for Codiak Biosciences, based on research at Gothenburg and Texas universities.

Alaska Permanent Fund and Qatar Investment Authority were among the investors in a series C round for Codiak Biosciences, based on research at Gothenburg and Texas universities.